Clinical Trials
2 trialsNCT04916509 2026-06-02
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
Pfizer
Completed
NCT07347600 2026-05-18
reaINAVO
Hoffmann-La Roche
Recruiting